Приобретенная гемофилия А с внутримышечной гематомой в необычном возрасте: клинический случай

acquired hemophilia A, acquired FVIII deficiency, factor VIII, bleeding, aPTT prolongation

1. Collins P.W., Percy C.L. Advances in the understanding of acquired haemophilia A: implications for clinical practice. Br J Haematol. 2010;148(2):183–94. doi: 10.1111/j.1365-2141.2009.07915.x.

2. Mo L., Bao G.C. Acquired factor VIII deficiency: two case reports and a review of literature. Exp Hematol Oncol. 2017;6:8. doi: 10.1186/s40164-017-0068-3.

3. Lee A.N., Werth V.P. Activation of autoimmunity following use of immunostimulatory herbal supplements. Arch Dermatol. 2004;140(6):723–7. doi: 10.1001/archderm.140.6.723.

4. Vintimilla M., Joseph A., Ranganathan P. Acquired factor VIII inhibitor in Sjögren’s syndrome. Arthritis Care Res (Hoboken). 2010;62(7):1047–50. doi: 10.1002/acr.20147.

5. Boggio L.N., Green D. Acquired hemophilia. Rev Clin Exp Hematol. 2001;5(4):389–404; quiz following 431. doi: 10.1046/j.1468-0734.2001.00049.x.

6. Collins P.W., Hirsch S., Baglin T.P., Dolan G., Hanley J., Makris M., Keeling D.M., Liesner R., Brown S.A., Hay C.R.M., UK Haemophilia Centre Doctors’ Organisation. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors’ Organisation. Blood. 2007;109(5):1870–7. doi: 10.1182/blood-2006-06-029850.

7. Franchini M., Zaffanello M., Lippi G. Acquired hemophilia in pediatrics: a systematic review. Pediatr Blood Cancer. 2010;55(4):606–11. doi: 10.1002/pbc.22657.

8. Moraca R.J., Ragni M.V. Acquired anti-FVIII inhibitors in children. Haemophilia. 2002;8(1):28–32. doi: 10.1046/j.1365-2516.2002.00574.x.

9. Green D., Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost. 1981;45(3):200–3. PMID: 6792737.

10. Chai-Adisaksopha C., Rattarittamrong E., Norasetthada L., Tantiworawit A., Nawarawong W. Younger age at presentation of acquired haemophilia A in Asian countries: a single-centre study and systematic review. Haemophilia. 2014;20(3):e205–10. doi: 10.1111/hae.12383.

11. Tiede A., Scharf R.E., Dobbelstein C., Werwitzke S. Management of acquired haemophilia A. Hamostaseologie. 2015;35(4):311–8. doi: 10.5482/HAMO-14-11-0064.

12. Tiede A., Werwitzke S., Scharf R.E. Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40(7):803–11. doi: 10.1055/s-0034-1390004.

13. Franchini M., Targher G., Manzato F., Lippi G. Acquired factor VIII inhibitors in oncohematology: a systematic review. Crit Rev Oncol Hematol. 2008;66(3):194–9. doi: 10.1016/j.critrevonc.2007.12.004.

14. Franchini M., Girelli D., Olivieri O., Bozzini C., Guiotto M., Zardini G., Lippi G., Manzato F., Gandin G. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. Haematologica. 2005;90(3):16. PMID: 15753057.

15. Gandini G., Franchini M., Manzato F., Lippi G., Aprili G. A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor. Haematologica. 1999;84(11):1054. PMID: 10553173.

16. Baudo F., Collins P., Huth-Kühne A., Lévesque H., Marco P., Nemes L., Pellegrini F., Tengborn L., Knoebl P., EACH2 registry contributors. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012;120(1):39–46. doi: 10.1182/blood-2012-02-408930.